SCHEMBL8887331

SCHEMBL8887331

Brc1c(COC2CCCCO2)cccc1COC1CCCCO1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.36
DHFR P00374 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CA2 P00918 4/20 0.34
CA1 P00915 3/20 0.34
CREBBP Q92793 2/20 0.33
EP300 Q09472 1/20 0.33
ICAM1 P05362 1/20 0.33
SELE P16581 1/20 0.33
TACR1 P25103 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
KCNA5 P22460 1/20 0.32
SCN5A Q14524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12375131 0.93 GABRA1 (0.46) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL18796462 0.90 KDM4C (0.38) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL2006340 0.86 TACR1 (0.45) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL29680564 0.86 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL20974574 0.86 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL3446404 0.86 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL18362480 0.85 KDM4C (0.38) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL8760072 0.84 KDM4C (0.38) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL13490826 0.83 KDM4C (0.43) KDM4CMEN1KMT2AL3MBTL1DHFR
SCHEMBL22070740 0.81 KDM4C (0.38) KDM4CMEN1KMT2AL3MBTL1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed
WO-2020186504-A1 A NEW TYPE OF ANTITUMOR COMPOUNDS: DERIVATIVES OF 7-PROPANAMIDE SUBSTITUTED BENZOXABOROLE SHANGHAI JIAO TONG UNIVERSITY (CN) 2020-09-24 WO disclosed
WO-2010045503-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-PROTOZOAL AGENTS ANACOR PHARMACEUTICALS, INC. (US) 2010-04-22 WO disclosed
WO-2010045505-A1 BORON-CONTAINING SMALL MOLECULES AS ANTI-PROTOZOAL AGENTS ANACOR PHARMACEUTICALS, INC (US) 2010-04-22 WO disclosed
US-5631264-A NEUROLOGICAL DISORDERS SANOFI WINTHROP, INC. (US) 1997-05-20 US disclosed
US-5554620-A Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof STERLING WINTHROP INC. (US) 1996-09-10 US disclosed
EP-0656359-A1 Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof STERLING WINTHROP INC. (US) 1995-06-07 EP disclosed